Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia releases overview of proposed IVD regulations

This article was originally published in RAJ Devices

Executive Summary

Australia’s Therapeutic Goods Administration has published an overview of the proposed new regulatory framework for in vitro diagnostic devices that it intends to introduce later this year1. Prior to the implementation of the new IVD framework, however, the Therapeutic Goods (Medical Devices) Regulations 2002 will have to be amended to include provision for IVDs. The TGA says that the regulations are currently being redrafted and when they are available, it will be organising information sessions for stakeholders.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC095633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel